Psychiatric Medication Intake in Suicide Victims: Gender Disparities and Implications for Suicide Prevention

• Antonios Paraschakis ^[1] ; Ioannis Michopoulos ^[2] ; Christos Christodoulou ^[2] ; Filippos Koutsaftis ^[3] ; Athanassios Douzenis ^[2]
  1. [1] Psychiatric Hospital of Attica “Dafni” Glyfada Attica Greece
  2. [2] 2nd Department of Psychiatry “Attikon” General Hospital Athens University Medical School Haidari Attica Greece
  3. [3] Athens Department of Forensic Medicine Athens Attica Greece

  Mostrar afiliaciones +
• Localización: Journal of forensic sciences, ISSN-e 1556-4029, ISSN 0022-1198, Vol. 61, Nº. 6, 2016, págs. 1660-1663
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Frequency and gender differences of psychiatric medication intake in a sample of suicide victims from the Athens Greater Area were investigated with a particular focus on the implications for suicide prevention. Data were collected from the toxicological analyses of the suicide cases of the period November 2007–October 2009. Information was available for 262 individuals, 196 men (74.8%) and 66 women (25.2%); 109 of these (41.6%) were receiving psychiatric medication(s). Women were statistically more frequently under treatment: antidepressants (32.8% vs. 11.3%, p < 0.001), antiepileptics (9.1% vs. 0.5%, p = 0.001), antipsychotics (24.2% vs. 9.2%, p = 0.003), and benzodiazepines (16.7% vs. 6.6%, p = 0.024). Campaigns aiming to bring men with psychological difficulties in contact with mental health services and to lessen the stigma of mental illness, together with better training of nonpsychiatrists into “suspecting”“male” depression, could be particularly helpful for decreasing male suicides. More thoughtful choice of psychiatric medication could possibly already prevent a number of female suicides.